Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis

Shin ichi Komiyama, Daisuke Aoki, Yukio Katsuki, Shiro Nozawa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To investigate differences in the biological characteristics of ovarian clear cell adenocarcinoma based on the presence/absence of endometriosis and tumor proliferative activity. Methods: Stage I ovarian clear cell adenocarcinoma patients were divided into groups with and without endometriosis, and immunohistochemical expression of proliferating cell nuclear antigen was determined in surgical specimens. Then xenograft models of human ovarian clear cell adenocarcinoma with or without human ectopic endometrium were created in severe combined immunodeficiency mice, and tumor growth was assessed from the wet weight and the bromodeoxyuridine uptake. Furthermore, a xenograft model of human endometriosis was made with or without ovarian clear cell adenocarcinoma and cytokine production was investigated. Results: The proliferating cell nuclear antigen labeling index was significantly lower in the tumors of patients with endometriosis compared to the tumors of patients without endometriosis. In tumor-bearing mice, the tumor weight and bromodeoxyuridine uptake were both significantly lower when ovarian clear cell adenocarcinoma was associated with endometriosis than in its absence. Release of transforming growth factor-β1 and interleukin-6 from the ectopic human endometrium was greater in the presence of clear cell adenocarcinoma than without it, and transforming growth factor-β1 levels showed a significant difference. Conclusion: The proliferative activity of early ovarian clear cell adenocarcinoma seems to depend on the association of this cancer with endometriosis. When endometriosis is associated with ovarian clear cell adenocarcinoma, there is a change of its cytokine production that may inhibit tumor growth.

Original languageEnglish
Pages (from-to)130-136
Number of pages7
JournalEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Volume127
Issue number1
DOIs
Publication statusPublished - 2006 Jul 1

Fingerprint

Clear Cell Adenocarcinoma
Endometriosis
Neoplasms
Proliferating Cell Nuclear Antigen
Transforming Growth Factors
Bromodeoxyuridine
Endometrium
Heterografts
Cytokines
Severe Combined Immunodeficiency
Growth
Tumor Burden
Interleukin-6
Weights and Measures

Keywords

  • Bromodeoxyuridine
  • Endometriosis
  • Ovarian clear cell adenocarcinoma
  • Proliferating cell nuclear antigen
  • SCID mouse
  • Stage I
  • Transforming growth factor-beta 1
  • Xenograft

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis. / Komiyama, Shin ichi; Aoki, Daisuke; Katsuki, Yukio; Nozawa, Shiro.

In: European Journal of Obstetrics Gynecology and Reproductive Biology, Vol. 127, No. 1, 01.07.2006, p. 130-136.

Research output: Contribution to journalArticle

@article{0653848faede4ef1a208b42da7fd33ef,
title = "Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis",
abstract = "Objective: To investigate differences in the biological characteristics of ovarian clear cell adenocarcinoma based on the presence/absence of endometriosis and tumor proliferative activity. Methods: Stage I ovarian clear cell adenocarcinoma patients were divided into groups with and without endometriosis, and immunohistochemical expression of proliferating cell nuclear antigen was determined in surgical specimens. Then xenograft models of human ovarian clear cell adenocarcinoma with or without human ectopic endometrium were created in severe combined immunodeficiency mice, and tumor growth was assessed from the wet weight and the bromodeoxyuridine uptake. Furthermore, a xenograft model of human endometriosis was made with or without ovarian clear cell adenocarcinoma and cytokine production was investigated. Results: The proliferating cell nuclear antigen labeling index was significantly lower in the tumors of patients with endometriosis compared to the tumors of patients without endometriosis. In tumor-bearing mice, the tumor weight and bromodeoxyuridine uptake were both significantly lower when ovarian clear cell adenocarcinoma was associated with endometriosis than in its absence. Release of transforming growth factor-β1 and interleukin-6 from the ectopic human endometrium was greater in the presence of clear cell adenocarcinoma than without it, and transforming growth factor-β1 levels showed a significant difference. Conclusion: The proliferative activity of early ovarian clear cell adenocarcinoma seems to depend on the association of this cancer with endometriosis. When endometriosis is associated with ovarian clear cell adenocarcinoma, there is a change of its cytokine production that may inhibit tumor growth.",
keywords = "Bromodeoxyuridine, Endometriosis, Ovarian clear cell adenocarcinoma, Proliferating cell nuclear antigen, SCID mouse, Stage I, Transforming growth factor-beta 1, Xenograft",
author = "Komiyama, {Shin ichi} and Daisuke Aoki and Yukio Katsuki and Shiro Nozawa",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.ejogrb.2005.11.030",
language = "English",
volume = "127",
pages = "130--136",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis

AU - Komiyama, Shin ichi

AU - Aoki, Daisuke

AU - Katsuki, Yukio

AU - Nozawa, Shiro

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Objective: To investigate differences in the biological characteristics of ovarian clear cell adenocarcinoma based on the presence/absence of endometriosis and tumor proliferative activity. Methods: Stage I ovarian clear cell adenocarcinoma patients were divided into groups with and without endometriosis, and immunohistochemical expression of proliferating cell nuclear antigen was determined in surgical specimens. Then xenograft models of human ovarian clear cell adenocarcinoma with or without human ectopic endometrium were created in severe combined immunodeficiency mice, and tumor growth was assessed from the wet weight and the bromodeoxyuridine uptake. Furthermore, a xenograft model of human endometriosis was made with or without ovarian clear cell adenocarcinoma and cytokine production was investigated. Results: The proliferating cell nuclear antigen labeling index was significantly lower in the tumors of patients with endometriosis compared to the tumors of patients without endometriosis. In tumor-bearing mice, the tumor weight and bromodeoxyuridine uptake were both significantly lower when ovarian clear cell adenocarcinoma was associated with endometriosis than in its absence. Release of transforming growth factor-β1 and interleukin-6 from the ectopic human endometrium was greater in the presence of clear cell adenocarcinoma than without it, and transforming growth factor-β1 levels showed a significant difference. Conclusion: The proliferative activity of early ovarian clear cell adenocarcinoma seems to depend on the association of this cancer with endometriosis. When endometriosis is associated with ovarian clear cell adenocarcinoma, there is a change of its cytokine production that may inhibit tumor growth.

AB - Objective: To investigate differences in the biological characteristics of ovarian clear cell adenocarcinoma based on the presence/absence of endometriosis and tumor proliferative activity. Methods: Stage I ovarian clear cell adenocarcinoma patients were divided into groups with and without endometriosis, and immunohistochemical expression of proliferating cell nuclear antigen was determined in surgical specimens. Then xenograft models of human ovarian clear cell adenocarcinoma with or without human ectopic endometrium were created in severe combined immunodeficiency mice, and tumor growth was assessed from the wet weight and the bromodeoxyuridine uptake. Furthermore, a xenograft model of human endometriosis was made with or without ovarian clear cell adenocarcinoma and cytokine production was investigated. Results: The proliferating cell nuclear antigen labeling index was significantly lower in the tumors of patients with endometriosis compared to the tumors of patients without endometriosis. In tumor-bearing mice, the tumor weight and bromodeoxyuridine uptake were both significantly lower when ovarian clear cell adenocarcinoma was associated with endometriosis than in its absence. Release of transforming growth factor-β1 and interleukin-6 from the ectopic human endometrium was greater in the presence of clear cell adenocarcinoma than without it, and transforming growth factor-β1 levels showed a significant difference. Conclusion: The proliferative activity of early ovarian clear cell adenocarcinoma seems to depend on the association of this cancer with endometriosis. When endometriosis is associated with ovarian clear cell adenocarcinoma, there is a change of its cytokine production that may inhibit tumor growth.

KW - Bromodeoxyuridine

KW - Endometriosis

KW - Ovarian clear cell adenocarcinoma

KW - Proliferating cell nuclear antigen

KW - SCID mouse

KW - Stage I

KW - Transforming growth factor-beta 1

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=33745420948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745420948&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2005.11.030

DO - 10.1016/j.ejogrb.2005.11.030

M3 - Article

C2 - 16442693

AN - SCOPUS:33745420948

VL - 127

SP - 130

EP - 136

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -